An understanding of the JAMA article is essential to prevent confusion about the crossover. Beginning with the basics about "real" GBM will help before undertaking the actual scientific article itself. It is too hard to start with the article before grasping some fundamentals.
The most significant is that 27 patients from the trial are still alive while all the patients in the ECA passed away. Did you deliberately neglect this part?
Market Data 
Markets 
AI
